N
NOWDiagnostics
And manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes
About NOWDiagnostics
NOWDiagnostics, Inc. (NOWDx), founded in 2014 and based in Springdale, Arkansas, develops and manufactures over-the-counter (OTC) and point-of-care (POC) diagnostic tests. Although the company was incorporated in 2014, the proprietary ADEXUSDx™ technology has been under development for over 15 years. Dr. Qinwei Shi was a key figure in revolutionizing the lateral flow assay testing that the company's products are based on.
The company's core business revolves around its ADEXUSDx™ product line, which uses a single drop of blood to deliver results for a variety of conditions within minutes. This technology is designed to be self-contained and easy to use, making it suitable for both professional healthcare settings (point-of-care) and for consumers to use at home (over-the-counter). The business model focuses on the manufacturing and sale of these diagnostic tests.
NOWDiagnostics aims to empower individuals to conduct their own health testing conveniently and receive rapid results. Their product suite includes tests for a range of common conditions, illnesses, and diseases, positioning the company as a key player in the shift towards decentralized diagnostics.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Springdale, United States
- Employees
- 36
- Open positions
- 1
- Dealroom signal
- 66.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jul 2024 | $23M | $90M | LabCorp · Kompass Kapital Management · DigitalDx Ventures | ↗ |
| GRANTOther financing | Aug 2020 | $696K | — | Undisclosed | — |
Growth signals
Latest recorded traffic for NOWDiagnostics is 2.8K monthly website visits, down 26.3% over the last three months. NOWDiagnostics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
DigitalDx Ventures
LabCorp
Kompass Kapital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NOWDiagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NOWDiagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.